Emergent BioSolutions
EBS
#6766
Rank
NZ$1.09 B
Marketcap
NZ$20.60
Share price
-1.24%
Change (1 day)
31.86%
Change (1 year)

Emergent BioSolutions (EBS) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$1.00 Billion

According to Emergent BioSolutions 's latest financial reports the company has NZ$1.00 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Emergent BioSolutions - Net assets on balance sheet (from 2004 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$0.85 B-16.62%
2023-12-31$NZ$1.02 B-53.03%
2022-12-31$NZ$2.18 B-7.36%
2021-12-31$NZ$2.35 B17.65%
2020-12-31$NZ$2.00 B24.08%
2019-12-31$NZ$1.61 B7.24%
2018-12-31$NZ$1.50 B17.32%
2017-12-31$NZ$1.28 B49.24%
2016-12-31$NZ$0.86 B-10.75%
2015-12-31$NZ$0.96 B36.58%
2014-12-31$NZ$0.70 B18.61%
2013-12-31$NZ$0.59 B10.76%
2012-12-31$NZ$0.53 B0.66%
2011-12-31$NZ$0.53 B10.27%
2010-12-31$NZ$0.48 B44.25%
2009-12-31$NZ$0.33 B-2.28%
2008-12-31$NZ$0.34 B53.74%
2007-12-31$NZ$0.22 B13.68%
2006-12-31$NZ$0.19 B124.89%
2005-12-31$NZ$87.39 M171.75%
2004-12-31$NZ$32.16 M
2002-12-31$NZ$7.93 M-110.21%
2001-12-31$-NZ$77.78 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Merck
MRK
NZ$89.85 B 8,811.07%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.35 B-65.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$36.65 B 3,535.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
NZ$1.03 B 2.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$161.14 B 15,882.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$12.55 B 1,145.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
NZ$13.15 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA